Our advertisers

Intersurgical Ltd
Baxter Healthcare Ltd
ParAid
Vygon (UK) Ltd
Medela AG
University of Plymouth
CliniMed Limited
Nutricia Ltd
Milton Pharmaceuticals Co UK Ltd
SBK (UK) Ltd
Inspiration Healthcare
vCreate Neonatal
The Brazelton Centre UK
Solus Medical Limited
Armstrong Medical
Central Medical Supplies Ltd

 

 

Volume 15/Issue 4, July 2019

PReCePT: reducing cerebral palsy through improving uptake of magnesium sulphate in preterm deliveries

Ellie Wetz


Neonatal healthcare professionals in every maternity unit in the country are working together with England’s 15 Academic Health Science Networks (AHSNs) to help improve outcomes for babies born very prematurely. Through the PReCePT (PReventing Cerebral palsy in PreTerm labour) programme, women threatened with very preterm birth at ≤30 weeks of pregnancy are offered magnesium sulphate, which has a protective effect on the preterm neonatal brain. As a result, fewer babies are likely to develop cerebral palsy, improving quality of life for preterm babies and their families.

Abbreviated: Please subscribe and log in to see the full article.

 
© Copyright of Stansted News Limited 2019. Terms & Conditions of reading. Privacy policy